Cardiac Oncology

Cardiac Oncology is the discipline that concentrates on the intersection of heart diseases and cancer. This field is growing at a faster rate because the survivors after cancer therapies are more prone to develop cardiovascular disease. The increase in cancer disease in the world has led to the emergence of numerous chemotherapeutic agents which are under preclinical or clinical studies. These agents are potent to cause damage to the heart (carddiotoxicity). Cardiotoxic effects of chemotherapy might be decreased by the concurrent use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers or beta-blockers. The use of diagnostic imaging, noninvasive stress testing and ambulatory blood pressure monitoring and ambulatory cardiac telemetry can help to identify carddiotoxicity and lead to the development of preventative strategies.

  • Cardiotoxic therapy
  • Cardiac biomarkers
  • Carddiotoxicity
  • Cardiac tumors

Related Conference of Cardiac Oncology

January 12-13, 2026

12th International Heart Conference

Dubai, UAE
March 18-19, 2026

15th World Heart Congress

Paris, France
March 23-24, 2026

37th Annual Cardiologists Conference

London, UK
March 23-24, 2026

41st World Cardiology Conference

London, UK
April 08-29, 2026

9th Annual Heart Rhythm Conference

Vienna, Austria
April 13-14, 2026

9th World Heart and Brain Conference

Tokyo, Japan
April 15-16, 2026

8th World Heart Congress

Tokyo, Japan
May 14-15, 2026

5th International Conference on Cardiology

Rome, Italy
May 21-22, 2026

15th World Congress on Cardiology

London, UK
June 15-16, 2026

7th European Summit on Cardiology Research

Zurich, Switzerland
July 29-30, 2026

30th World Cardiology Conference

Paris, France
August 17-18, 2026

4th International Conference on World Heart Care

Toronto, Canada
August 24-25, 2026

15th World Heart Congress

London, UK
August 27-28, 2026

40th European Cardiology Conference

Berlin, Germany

Cardiac Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in